Intermittent Vs Continuous Androgen Deprivation in Patients With Advanced Prostate Cancer.

Trial Profile

Intermittent Vs Continuous Androgen Deprivation in Patients With Advanced Prostate Cancer.

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 16 Jan 2017

At a glance

  • Drugs Goserelin (Primary)
  • Indications Prostate cancer
  • Focus Therapeutic Use
  • Acronyms FINNPROSTATE Study VII
  • Most Recent Events

    • 28 Feb 2012 Results presented at the 27th Congress of the European Association of Urology.
    • 01 Jan 2010 Primary endpoint 'Time-to-disease-progression' has been met.
    • 05 Jun 2009 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top